Press Releases

  • Jul. 2016
    Dr. Andreas Rummelt, pharma industry expert and former CEO of Sandoz, was elected as new supervisory board member at LEUKOCARE’s annual shareholder meeting on July 12th.
  • Mar. 2016
    LEUKOCARE launches comprehensive website update
  • Jul. 2015
    LEUKOCARE receives growth capital funding by LifeCare Partners and strengthens its board with industry experts
  • Apr. 2015
    LEUKOCARE participates in European consortium to validate blood-based biomarkers for cancer
  • Apr. 2014
    New book release covering Biofunctional Surface Engineering of medical devices
  • Mar. 2014
    LEUKOCARE is pleased to announce the launch of its new website in March 2014
  • Dec. 2013
    LEUKOCARE licenses its stabilizing and protecting technologies for veterinarian vaccine
  • Oct. 2013
    Scil Proteins and LEUKOCARE develop a stabilized recombinant human thrombin manufactured in bacteria
  • Oct. 2013
    Innovative Influenza A vaccine formulation increases stability and provides new options for production and storage
  • Oct. 2013
    Xenios and LEUKOCARE announce strategic partnership in the field of anti-inflammatory coatings for next generation extracorporeal support systems